Health Care Stocks Lower

Health Care Stocks Lower

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index sinking about 0.4% while shares of health care companies in the S&P 500 were down almost 0.6% as a group. In company news, Myovant Sciences Ltd (MYOV) jumped on Thursday, reaching a session high of $12.47 a share, after analysts at Evercore ISI today began analyst coverage of the early-state biotech company with an outperform rating […]

Read More ˃
Novo Nordisk Raises 2017 Growth Forecasts

Novo Nordisk Raises 2017 Growth Forecasts

Novo Nordisk, a Danish drugmaker best known for its diabetes and obesity medications, lifted its sales and operating profit growth forecasts for the full year after posting increases in both metrics for its second quarter. Net profit was 9.95 billion Danish kroner ($1.57 billion), or 4.01 Danish kroner per share, in the quarter, compared with 9.97 Danish kroner, or 3.92 Danish kroner per share, in the same period a year […]

Read More ˃
athenahealth Launches Strategic Review

athenahealth Launches Strategic Review

athenahealth gained more than 1% after the company said it is conducting a strategic review of the company’s operational and financial strategy, leadership and governance. It said it has identified approximately $100 million in cost-savings opportunities and will provide additional information regarding details of these strategic initiatives, including plans to significantly increase operating margins, in 2018 by its Q3 earnings reporting date in October. It also plans to create a […]

Read More ˃
ABIOMED Fiscal Q1 Results Top Expectations

ABIOMED Fiscal Q1 Results Top Expectations

ABIOMED shares were barely higher pre-market Thursday after the company reported fiscal Q1 EPS of $0.82 per share, up from $0.29 per share a year ago. Analysts polled by Capital IQ expected earnings of $0.42 per share. The company said Q1 earnings benefited from adoption of a new accounting standard that required $16.8 million, or $0.37 per diluted share, of excess tax benefits related to employee share-based compensation awards to […]

Read More ˃
Moody’s Tops Q2 Street Views on EPS and Revenues

Moody’s Tops Q2 Street Views on EPS and Revenues

Moody’s, the credit-rating agency, Friday reported earnings and revenues above Street views, and also boosted its full year guidance. Adjusted earnings were of $1.51 per diluted share, above the Street view of $1.34 as compiled by Capital IQ, and also above the $1.30 reported a year earlier. The agency reported Q2 revenues of $1.00 billion, above the Street view of $968.8 million, and above the $928.9 million reported a year […]

Read More ˃